Earnings Insights

Kaka Industries Q1 FY26 quarterly results analysis. - Targeting 40% volume growth for FY 2025-26. Market Cap ₹280, P/E 14.9. AI-powered earnings insights.

5 Aug 2026

Nexus Select Q4 FY25 quarterly results analysis. - Long-term consumption growth is expected around 7%-7.5%; currently at 6% with potential improvement as government’s INR 1 lakh crore stimulus starts circulating (Dalip Sehgal, p14). Market Cap ₹25,378, P/E 57.6. AI-powered earnings insights.

5 Aug 2026

Mankind Pharma Q2 FY26 quarterly results analysis. - BSV (Biosimilars) is expected to grow at around 18%-20% overall in the coming year, with sequential quarterly improvement (Q2 > Q1, Q3 > Q2). Market Cap ₹99,649, P/E 46.7. AI-powered earnings insights.

5 Aug 2026

Mankind Pharma Q1 FY26 quarterly results analysis. - Expectation to outperform Indian Pharmaceutical Market (IPM) by about 1.2x in domestic revenue growth for FY '26. Market Cap ₹99,649, P/E 46.7. AI-powered earnings insights.

5 Aug 2026

Mankind Pharma Q4 FY25 quarterly results analysis. - Mankind Pharma aims for sustainable long-term growth, focusing on solid foundations and efficiency improvements. Market Cap ₹99,649, P/E 46.7. AI-powered earnings insights.

5 Aug 2026

Avalon Tech Q2 FY26 quarterly results analysis. - Avalon anticipates doubling revenues from FY '24 to FY '27, reflecting strong confidence in growth momentum. Market Cap ₹12,180, P/E 91.2. AI-powered earnings insights.

5 Aug 2026

Cube Highways Q4 FY26 quarterly results analysis. - Strong traffic growth of 9.4% YoY observed recently, supported by sustained increase in passenger car traffic due to rising vehicle sales and disposable incomes. Market Cap ₹21,227, P/E 144.5. AI-powered earnings insights.

5 Aug 2026

De Neers Tools Q1 FY26 quarterly results analysis. - Targeting 25% to 30% CAGR growth in revenue, driven by strong brand presence and expanded dealer-distributor network (Page 8, 13). Market Cap ₹156, P/E 6.2. AI-powered earnings insights.

5 Aug 2026

Shera Energy Q4 FY26 quarterly results analysis. - The company expects to double its top-line revenue within the next 2 to 3 years, driven by capacity expansions and operational scaling. Market Cap ₹406, P/E 11.9. AI-powered earnings insights.

5 Aug 2026

Shera Energy Q3 FY26 quarterly results analysis. - Shera Energy expects revenue growth of 20% to 40% annually, with a 30% growth in H1 FY'26 continuing into FY'26-27. Market Cap ₹406, P/E 11.9. AI-powered earnings insights.

5 Aug 2026

Shera Energy Q4 FY25 quarterly results analysis. - Shera Energy targets substantial sales and volume growth driven primarily by increased production capacity and market demand. Market Cap ₹406, P/E 11.9. AI-powered earnings insights.

5 Aug 2026

All E Tech Q4 FY25 quarterly results analysis. - Pipeline is healthy with several conversations at advanced stages, indicating potential customer additions in coming quarters. Market Cap ₹269, P/E 10.1. AI-powered earnings insights.

5 Aug 2026

KFin Technolog. Q3 FY26 quarterly results analysis. - Domestic mutual fund business expected to grow at 15%-20% annually, driven by financial inclusion and expanding market size. Market Cap ₹16,431, P/E 46.9. AI-powered earnings insights.

5 Aug 2026

KFin Technolog. Q1 FY26 quarterly results analysis. - KFin Technologies expects continued strong growth with guidance of 18%-20% top-line growth. Market Cap ₹16,431, P/E 46.9. AI-powered earnings insights.

5 Aug 2026

KFin Technolog. Q4 FY25 quarterly results analysis. - Revenue grew 33% year-on-year with a consistent broad-based expansion across all segments. Market Cap ₹16,431, P/E 46.9. AI-powered earnings insights.

5 Aug 2026

Aarti Pharma Q3 FY26 quarterly results analysis. - CDMO business is expected to exceed earlier 30%-40% growth guidance in FY '26, with substantial sales in H2 and next year contributing to overall revenue growth. Market Cap ₹6,205, P/E 35.1. AI-powered earnings insights.

5 Aug 2026

Aarti Pharma Q2 FY26 quarterly results analysis. - CDMO segment expected to grow 30%-40% this year, aiming for Rs. Market Cap ₹6,205, P/E 35.1. AI-powered earnings insights.

5 Aug 2026

Aarti Pharma Q1 FY26 quarterly results analysis. - The company targets around 15% revenue growth in FY'26. Market Cap ₹6,205, P/E 35.1. AI-powered earnings insights.

5 Aug 2026

Keystone Realtor Q2 FY26 quarterly results analysis. - Keystone Realtors reported record Q1 FY '26 presales of INR 1,068 crores, a 75% YoY growth, and launches worth INR 3,967 crores, doubling last year's same period. Market Cap ₹4,898, P/E 41.7. AI-powered earnings insights.

5 Aug 2026

Keystone Realtor Q4 FY25 quarterly results analysis. - Keystone Realtors has demonstrated strong pre-sales growth, achieving Rs. Market Cap ₹4,898, P/E 41.7. AI-powered earnings insights.

5 Aug 2026